ES | EN

About Us

Dreamgenics is a Spanish biotechnology company specializing in genomics, bioinformatics, and genetic diagnostics. Since 2011, we have been developing NGS-based solutions to transform complex genomic data into useful information for research and clinical practice.

+15years of experience in NGS data analysis
+16,000samples analyzed
+12,000tests performed
ISOManagement systems certified to ISO 9001 and ISO/IEC 27001

Our History

These are some of the milestones that have marked our evolution, from our first bioinformatics tools to a comprehensive genomics service.

  1. 2011

    Dreamgenics Is Born

    One of Spain's pioneering companies in the development of bioinformatics tools for NGS data

  2. 2012

    Genome One

    Development of our Genome One software for the bioinformatic analysis of NGS data

  3. 2014

    Genome One Reports

    Launch of our interactive results delivery platform, Genome One Reports

  4. 2015

    Bioinformatics

    Specialization as a provider of bioinformatics analysis services for NGS data

  5. 2016

    First European project

    We are participating in a project ERA-NET TRANSCAN on intratumoral heterogeneity in chronic lymphocytic leukemia

  6. 2018

    Second European project

    Interreg SUDOE Project for the Early Detection of Hearing Loss in Children, in collaboration with eight organizations from three countries

  7. 2019

    Certified Quality and Safety

    We have our management systems certified to the ISO 9001 and ISO/IEC 27001 standards by AENOR

  8. 2020

    Growth and Diversification

    Capacity building and the development of new solutions tailored to market needs

  9. 2022

    Genetic diagnosis

    Addition of genetic testing to our range of services, covering ten medical specialties

  10. 2024

    NGS sequencing

    Integration of NGS sequencing into our in-house capabilities using IVD equipment

  11. 2025

    Third European project

    Interreg SUDOE Project to Identify Risk Profiles for Cisplatin-Induced Hearing Loss

  12. Today

    Comprehensive Genomic Capabilities

    Sequencing, bioinformatics, and genetic diagnostics for the pharmaceutical, clinical, and research sectors

At Dreamgenics, we have been able to evolve in step with the field of genomic medicine thanks to a team that shares knowledge, experience, and diverse perspectives to tackle every challenge with rigor and commitment.

This strength allows us to understand our clients' needs, offer solutions tailored to each project, and build lasting relationships based on trust and satisfaction with the results.

Carlos MartínezCarlos Martínez, Ph.D.CEO and Chief Technical Officer

Why Dreamgenics

We are a trusted partner with a personalized and flexible approach that adapts to the needs of each project.

Advice and Experience

More than 16,000 samples analyzed and 12,000 tests conducted attest to our expertise. We work closely with each client to understand their goals and provide scientific and technical support throughout the entire project.

  • Study Design
  • Scientific Support
  • Technical Support
  • Interpretation of Results

Technology with IVD marking

Library preparation and sequencing on IVD-marked equipment.

  • Agilent MagnisDx
  • MGISP-100
  • MGISP-960
  • DNBSEQ-G400

Quality and Safety

We operate under quality management and information security management systems certified to ISO 9001 and ISO/IEC 27001.

View Certifications

Data on our own infrastructure

Genomic and clinical data processed and stored in our own data center, under a certified information security system.

Interactive Results

Our Genome One Reports web platform allows you to explore the results interactively, helping you get the most out of the results.

Learn About Genome One Reports
genome-one-reports.dreamgenics.com
RNA Biotypes58 %mRNAlncRNAPseudogenessnoRNAmiRNAOthers
PCAControlTreaty
Volcano plotCancelUpload
Conditional expressionControlDose 1Dose 2Episode 3
Enriched Routes-2-1012NESmuscle contractionactin filament-based movementblood vessel morphogenesisangiogenesiscell-matrix adhesioncirculatory system processresponse to interferonDNA replicationDefense Response to a Viruscytoplasmic translation
Heat MapFOSBEGR3NR4A1JUNBIL1BCCL3HBBCA1MYL9TPM2

Centers and Institutions

Hospitals, universities, and research institutes in Europe and Latin America rely on Dreamgenics for their genomics projects.

HeadquartersOviedo (Spain)
  • La Princesa University Hospital
  • Ramón y Cajal University Hospital
  • San Carlos Clinical Hospital
  • 12 de Octubre University Hospital
  • Puerta de Hierro University Hospital, Majadahonda
  • Asturias Central University Hospital (HUCA)
  • University of Navarra Clinic
  • Salamanca University Hospital
  • Son Espases University Hospital
  • National Cancer Research Center (CNIO)
  • National Center for Cardiovascular Research (CNIC)
  • National Center for Biotechnology (CNB-CSIC)
  • Severo Ochoa Center for Molecular Biology (CBM)
  • Cancer Research Center (CIC)
  • IdiPAZ, La Paz University Hospital Research Institute
  • IIS Jiménez Díaz Foundation
  • i+12, 12 de Octubre Hospital Research Institute
  • CIMA University of Navarra
  • IDIVAL, Valdecilla Research Institute
  • INCLIVA
  • IDIBAPS
  • Navarrabiomed
  • INIBIC, Institute for Biomedical Research in A Coruña
  • IDIS, Institute for Health Research in Santiago de Compostela
  • CiMUS
  • ISPA, Institute for Health Research of the Principality of Asturias
  • FINBA, Foundation for Biomedical Research and Innovation of the Principality of Asturias
  • Complutense University of Madrid
  • University of Oviedo
  • University of Salamanca
  • University of Barcelona
  • Francisco de Vitoria University